New microbicide enters clinical testing.
Hanna
L
L
D000282:Administration, Intravaginal; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use*; D017321:Clinical Trials, Phase I as Topic; D003271:Contraceptive Agents, Female / Q000627:therapeutic use*; D005260:Female; D005782:Gels; D015658:HIV Infections / Q000517:prevention & control; D006801:Humans; D012749:Sexually Transmitted Diseases / Q000517:prevention & control*
D000891:Anti-Infective Agents, Local; D003271:Contraceptive Agents, Female; D005782:Gels